Deep brain stimulation for Parkinson's disease: Surgical issues

Movement Disorders

Volumn 21, Issue SUPPL. 14, 2006, Pages

  Rezai, Ali R ^a   Kopell, Brian H ^b   Gross, Robert E ^c   Vitek, Jerrold L ^a   Sharan, Ashwini D ^d   Limousin, Patricia ^e   Benabid, Alim Louis ^f  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e Queen's Square Hospital   (United Kingdom)

^f UNIV GRENOBLE ALPES   (France)

Author keywords

Deep brain stimulation surgery; Macrostimulation; Microelectrode recording; Microstimulation; Parkinson's disease; Stereotaxis; Surgical complications

Indexed keywords

ANTIPARKINSON AGENT;

BRAIN DEPTH STIMULATION; CONSENSUS DEVELOPMENT; DIAGNOSTIC IMAGING; DRUG WITHDRAWAL; ELECTRODE; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MEDICAL SOCIETY; MICROELECTRODE; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; PULSE GENERATOR; RADIATION SAFETY; RECORDING; REVIEW; STEREOTAXIC SURGERY; SURGICAL EQUIPMENT; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT PLANNING;

BRAIN; DEEP BRAIN STIMULATION; ELECTRODES; EQUIPMENT DESIGN; HUMANS; MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE;

EID: 33745812052     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20956     Document Type: Review

References (100)

1. Maciunas RJ, Galloway RL Jr, Latimer JW. The application accuracy of stereotactic frames. Neurosurgery 1994;35:682-694.
2. Benabid AL, Koudsie A, Benazzouz A, et al. Subthalamic stimulation for Parkinson's disease. Arch Med Res 2000;31:282-289.
3. Cuny E, Guehl D, Burbaud P, Gross C, Dousset V, Rougier A. Lack of agreement between direct magnetic resonance imaging and statistical determination of a subthalamic target: the role of electrophysiological guidance. J Neurosurg 2002;97:591-597.
4. Schuurman PR, de Bie RM, Majoie CB, Speelman JD, Bosch DA. A prospective comparison between three-dimensional magnetic resonance imaging and ventriculography for target-coordinate determination in frame-based functional stereotactic neurosurgery. J Neurosurg 1999;91:911-914.
5. Walton L, Hampshire A, Forster DM, Kemeny AA. A phantom study to assess the accuracy of stereotactic localization, using T1-weighted magnetic resonance imaging with the Leksell steremactic system. Neurosurgery 1996;38:170-176.
6. Duffner F, Schiffbauer H, Breit S, Friese S, Freudenstein D. Relevance of image fusion for target point determination in functional neurosurgery. Acta Neurochirurgica 2002;144:445-451.
7. Starr PA, Christine CW, Theodosopoulos PV, et al. Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg 2002;97:370-387.
8. Alterman RL, Reiter GT, Shils J, et al. Targeting for thalamic deep brain stimulator implantation without computer guidance: assessment of targeting accuracy. Stereotact Funct Neurosurg 1999;72:150-153.
9. Aziz TZ, Nandi D, Parkin S, et al. Targeting the subthalamic nucleus. Stereotact Fund Neurosurg 2001;77:87-90.
10. Bejjani BP, Dormont D, Pidoux B, et al. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg 2000;92:615-625.
11. Egidi M, Rampini P, Locatelli M, et al. Visualisation of the subthalamic nucleus: a multiple sequential image fusion (MuSIF) technique for direct stereotaxic localisation and postoperative control. Neurol Sci 2002;23(Suppl. 2):71-72.
12. Liu X, Rowe J, Nandi D, et al. Localisation of the subthalamic nucleus using Radionics Image Fusion and Stereoplan combined with field potential recording: a technical note. Stereotact Funct Neurosurg 2001;76:63-73.
13. Zonenshayn M, Rezai AR, Mogilner AY, Beric A, Sterio D, Kelly PJ. Comparison of anatomic and neuropbysiological methods for subthalamic nucleus targeting. Neurosurgery 2000;47: 282-292.
14. Vitek JL, Bakay RA, Hashimoto T, et al. Microelectrode-guided pallidotomy: technical approach and its application in medically intractable Parkinson's disease. J Neurosurg 1998;88:1027-1043.
15. Zhu XL, Hamel W, Schrader B, et al. Magnetic resonance imaging-based morphometry and landmark correlation of basal ganglia nuclei. Acta Neurochirurgica 2002;144:959-969,
16. Pollo C, Meuli R, Maeder P, Vingerhoets F, Ghika J, Villemure JG. Subthalamic nucleus deep brain stimulation for Parkinson's disease: magnetic resonance imaging targeting using visible anatomical landmarks. Stereotact Funct Neurosurg 2003;80:76-81.
17. Iacopino DG, Conti A, Angileri FF, Tomasello F. Different methods for anatomical targeting. J Neurosurg Sci 2003;47:18-25.
18. Rampini PM, Locatelli M, Alimehmeti R, et al, Multiple sequential image-fusion and direct MRI localisation of the subthalamic nucleus for deep brain stimulation, J Neurosurg Sci 2003;47:33-39.
19. Hariz MI, Fodstad H. Do microelectrode techniques increase accuracy or decrease risks in pallidotomy and deep brain stimulation? a critical review of the literature. Stereotact Funct Neurosurg 1999;72:157-169.
20. Palur RS, Berk C, Schulzer M, Honey CR. A metaanalysis comparing the results of pallidotomy performed using microelectrode recording or macroelectrode stimulation. J Neurosurg 2002; 96:1058-1062.
21. Hariz MI. Safety and risk of microelectrode recording in surgery for movement disorders. Stereotact Funct Neurosurg 2002;78: 146-157.
22. Deep-Brain Stimulation for Parkinson's Disease Study G. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001; 345:956-963.
23. Maltete D, Navarro S, Welter ML, et al. Subthalamic stimulation in Parkinson disease: with or without anesthesia? Arch Neurol 2004;61:390-392.
24. Hutchison WD, Allan RJ, Opitz H, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 1998;44:622-628.
25. Garonzik IM, Hua SE, Ohara S, Lenz FA. Intraoperative microelectrode and semi-microelectrode recording during the physiological localization of die thalamic nucleus ventral intermediate, Mov Disord 2002;17:135-144.
26. Lozano AM, Hutchison WD, Tasker RR, Lang AE, Junn F, Dostrovsky JO. Microelectrode recordings define the ventral posteromedial pallidotomy target. Stereotact Funct Neurosurg 1998; 71:153-163.
27. Benabid AL, Pollak P, Gao D, et al. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg 1996;84:203-214.
28. Albe-Fessard D. Evoked potential recording in functional neurosurgery: I, use of thalamic evoked potentials to improve the stereotactic localization of electrodes in the human brain. In: Gildenberg PL, Tasker R, editors. Textbook of stereotactic and functional neurosurgery. New York: McGraw-Hill; 1998. p 911-924.
29. Obwegeser AA, Uitti RJ, Witte RJ, Lucas JA, Turk MF, Wharen RE Jr. Quantitative and qualitative outcome measures after thalamic deep brain stimulation to treat disabling tremors. Neurosurgery 2001;48:274-281.
30. Rehncrona S, Johnels B, Widner H, Tornqvist AL, Hariz M, Sydow O. Long-term efficacy of thalamic deep brain stimulation for tremor: Double-blind assessments. Mov Disord 2003;18:163-170.
31. Guridi J, Rodriguez-Oroz MC, Lozano AM, et al. Targeting the basal ganglia for deep brain stimulation in Parkinson's disease. Neurology 2000;55:21-28.
32. Abosch A, Hutchison WD, Saint-Cyr JA, Dostrovsky JO, Lozano AM. Movement-related neurons of the subthalamic nucleus in patients with Parkinson disease. J Neurosurg 2002;97: 1167-1172.
33. Benazzouz A, Breit S, Koudsie A, Pollak P, Krack P, Benabid AL. Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease. Mov Disord 2002;17:145-149.
34. Guridi J, Rodriguez-Oroz MC, Ramos E, Linazasoro G, Obeso JA. Discrepancy between imaging and neurophysiology in deep brain stimulation of medial pallidum and subthalamic nucleus in Parkinson's disease. Neurologia 2002;17:183-192.
35. Lanotte MM, Rizzone M, Bergamasco B, Faccani G, Melcarne A, Lopiano L. Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation. J Neurol Neurosurg Psychiatry 2002; 72:53-58.
36. Lemaire JJ, Durif F, Boire JY, Debilly B, Irthum B, Chazal J. Direct stereotactic MRI location in the globus pallidus for chronic stimulation in Parkinson's disease. Acta Neurochirurgica 1999; 141:759-765.
37. Lopez-Flores G, Miguel-Morales J, Teijeiro-Amador J, et al. Anatomic and neurophysiological methods for the targeting and lesioning of the subthalamic nucleus: Cuban experience and review. Neurosurgery 2003;52:817-830.
38. Lozano AM, Hutchison WD. Microelectrode recordings in the pallidum. Mov Disord 2002;17(Suppl. 3):150-154.
39. Sterio D, Zonenshayn M, Mogilner AY, et al. Neurophysiological refinement of subthalamic nucleus targeting. Neurosurgery 2002; 50:58-67.
40. Tamma F, Caputo E, Chiesa V, et al. Anatomo-clinical correlation of intraoperative stimulation-induced side-effects during HF-DBS of the subthalamic nucleus. Neurol Sci 2002;23:109-110.
41. Tan AK, Yeo TT, Tjia HT, Khanna S, Nowinski WL, Stereotactic microelectrode-guided posteroventral pallidotomy and pallidal deep brain stimulation for Parkinson's disease. Ann Acad Med Singapore 1998;27:767-771.
42. Houeto JL, Welter ML, Bejjani PB, et al. Subthalamic stimulation in Parkinson disease: intraoperative predictive factors. Arch Neurol 2003;60:690-694.
43. Anagnostou E, Sporer B, Steude U, Kempermann U, Buttner U, Botzel K. Contraversive eye deviation during deep brain stimulation of the globus pallidus internus. Neurology 2001;56:1396-1399.
44. Pollak P, Krack P, Fraix V, et al. Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson's disease. Mov Disord 2002;17:155-161.
45. Wester K, Hauglie-Hanssen E. The prognostic value of intraoperative observations during thalamotomy for parkinsonian tremor. Clin Neurol Neurosurg 1992;94:25-30.
46. Tasker RR. Deep brain stimulation is preferable to thalamotomy for tremor suppression. Surg Neurol 1998;49,145-153.
47. Vesper J, Chabardes S, Fraix V, Sunde N, Ostergaard K, the Kinetra Study G. Dual channel deep brain stimulation system (Kinetra) for Parkinson's disease and essential tremor: a prospective multicentre open label clinical study. J Neurol Neurosurg Psychiatry 2002;73:275-280.
48. Favre J, Taha JM, Steel T, Burchiel KJ, Anchoring of deep brain stimulation electrodes using a microplate: technical note. J Neurosurg 1996;85:1181-1183.
49. Yamamoto T, Katayama Y, Kobayashi K, Oshima H, Fukaya C. Dual-floor buff hole adjusted to burr-hole ring and cap for implantation of stimulation electrodes. Technical note, J Neurosurg 2003;99:783-784.
50. Funkiewiez A, Ardouin C, Caputo E, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behavior in Parkonson's disease. J Neurol Neurosurg Psychiatry 2004;75:834-839.
51. Morrison CE, Borod JC, Perrine K, et al. Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson's disease. Arch Clin Neuropsychol 2004;19:165-181.
52. Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000;123:2091-2108.
53. Sturman MM, Vaillancourt DE, Metman LV, Bakay RA, Corcos DM. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease. Brain 2004;127:2131-2143.
54. Vaillancourt DE, Prodoehl J, Verhagen Metman L, Bakay RA, Corcos DM. Effects of deep brain stimulation and medication on bradykinesia and muscle activation in Parkinson's disease. Brain 2004;127:491-504.
55. Spiegel J, Fuss G, Backens M, et al. Transient dystonia following magnetic resonance imaging in a patient with deep brain stimulation electrodes for the treatment of Parkinson disease: case report. J Neurosurg 2003;99:772-774.
56. Rezai AR, Finelli D, Rugieri P, Tkach J, Nyenhuis JA, Shellock FG. Neurostimulators: potential for excessive heating of deep brain stimulation electrodes during magnetic resonance imaging. J Magn Reson Imaging 2001;14:488-489.
57. Rezai AR, Finelli D, Nyenhuis JA, et al. Neurostimulation systems for deep brain stimulation: in vitro evaluation of magnetic resonance imaging-related heating at 1.5 tesla. J Magn Reson Imaging 2002;15:241-250.
58. Uitti RJ, Tsuboi Y, Pooley RA, et al. Magnetic resonance imaging and deep brain stimulation. Neurosurgery 2002;51:1423-1428.
59. Sharan A, Rezai AR, Nyenhuis JA, et al. MR safety in patients with implanted deep brain stimulation systems (DBS). Acta Neurochirurgica 2003;87(Suppl.):141-145.
60. Rezai AR, Phillips M, Baker KB, et al. Neurostimulation system used for deep brain stimulation (DBS): MR safety issues and implications of failing to follow safety recommendations. Invest Radiol 2004;39:300-303.
61. Yelnik J, Damier P, Demeret S, et al. Localization of stimulating electrodes in patients with Parkinson disease by using a three-dimensional atlas-magnetic resonance imaging coregistration method. J Neurosurg 2003;99:89-99.
62. Ferroli P, Franzini A, Marras C, Maccagnano E, D'Incerti L, Broggi G. A simple method to assess accuracy of deep brain stimulation electrode placement: pre-operative stereotactic CT + postoperative MR image fusion. Stereotact Funct Neurosurg 2004;82:14-19.
63. Hariz MI, Krack P, Melvill R, et al. A quick and universal method for stereotactic visualization of the subthalamic nucleus before and after implantation of deep brain stimulation electrodes. Stereotact Funct Neurosurg 2003;80:96-101.
64. Obwegeser AA, Uitti RJ, Turk MF, et al. Simultaneous thalamic deep brain stimulation and implantable cardioverter-defibrillator. Mayo Clin Proc 2001;76:87-89.
65. Rosenow JM, Mogilnert AY, Ahmed A, Rezai AR. Deep brain stimulation for movement disorders. Neurol Res 2004;26:9-20.
66. Senatus PB, McClelland S III, Ferris AD, et al. Implantation of bilateral deep brain stimulators in patients with Parkinson disease and preexisting cardiac pacemakers: report of two cases. J Neurosurg 2004;101:1073-1077.
67. Rosenow JM, Tarkin H, Zias E, Sorbera C, Mogilner A. Simultaneous use of bilateral subthalamic nucleus stimulators and an implantable cardiac defibrillator: case report. J Neurosurg 2003; 99:167-169.
68. Nutt JG, Anderson VC, Peacock JH, Hammerstad JP, Burchiel KJ. DBS and diathermy interaction induces severe CNS damage. Neurology 2001;56:1384-1386.
69. Umemura A, Jaggi JL, Hurtig HI, et al. Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg 2003;98:779-784.
70. Oh MY, Hodaie M, Kim SH, Alkhani A, Lang AE, Lozano AM. Deep brain stimulator electrodes used for lesioning: proof of principle. Neurosurgery 2001;49:363-367.
71. Beric A, Kelly PJ, Rezai A, et al. Complications of deep brain stimulation surgery. Stereotact Funct Neurosurg 2001;77:73-78.
72. Baddour LM. Long-term suppressive antimicrobian therapy for intravascular device-related infections. Am J Med Sci 2001;322: 209-212.
73. Chamis AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation 2001;104:1029-1033.
74. Cohen MI, Bush DM, Gaynor JW, Vetter VL, Tanel RE, Rhodes LA. Pediatric pacemaker infecions: twenty years of experience. J Thorac Cardiovasc Surg 2002;124:821-827.
75. Mounsey JP, Griffith MJ, Tynan M, et al. Antibiotic prophylaxis in permanent pacemaker implantation: a prospective randomised trial. Br Heart J 1994;72:339-343.
76. Wade JS, Cobbs CG. Infections in cardiac pacemakers. Curr Clin Top Infect Dis 1988;9:44-61.
77. Yamada M, Takeuchi S, Shiojiri Y, et al. Surgical lead-preserving procedures for pacemaker pocket infection. Ann Thorac Surg 2002;74:1494-1499.
78. Bracke FA, Meijer A, van Gelder MA. Pacemaker lead complications: when is extraction appropriate and what can we learn from published data? Heart 2001;85:254-259.
79. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000; 133:604-608.
80. Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 1998;97:1796-1801.
81. Langley JM, LeBlanc JC, Drake J, Milner R. Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis. Clin Infect Dis 1993;17:98-103.
82. Dwivedi SK, Saran RK, Khera P, Tripathi N, Kochar AK, Naran VS, Puri VK. Short-term (48 hours) versus long-term (7 days) antibiotic prophylaxis for permanent pacemaker implantation. Ind Heart J 2001;53:740-742.
83. Varley GA, Meisler DM, Benes SC, McMahon JT, Zakov ZN, Fryczkowski A. Hibiclens keratopathy: a clinicopathologic case report. Cornea 1990;9:341-346.
84. Horgan MA, Piatt JH Jr. Shaving of the scalp may increase the rate of infection in CSF shunt surgery. Pediatr Neurosurg 1997; 26:180-184.
85. Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 2001;94:195-201.
86. Brook I, Frazier EH. Role of aerobic and anaerobic bacteria in pacemaker infections. Clin Infect Dis 1997;24:1010-1012.
87. Penk A, Pittrow L. Role of fluconazole in the long-term suppressive therapy of fungal infections in patients with artificial implants. Mycoses 1999;42:91-96.
88. Hariz MI. Complications of deep brain stimulation surgery. Mov Disord 2002;17:162-166.
89. Oh MY, Abosch A, Kim SH, Lang AE, Lozano AM. Long-term hardware-related complications of deep brain stimulation. Neurosurgery 2002;50:1268-1274.
90. Choux M, Genitori L, Lang D, Lena G. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 1992;77: 875-880.
91. Garcia-Rinaldi R, Revuelta JM, Bonnington L, Soltero-Harrington L. The exposed cardiac pacemaker: treatment by subfascial pocket relocation. J Thorac Cardiovasc Surg 1985;89:136-141.
92. Gillette PC, Edgerton J, Kratz J, Zeigler V. The subpectoral pocket: the preferred implant site for pediatric pacemakers. Pacing Clin Electrophysiol 1991;14:1089-1092.
93. Hamel W, Schrader B, Weinert D, et al. Technical complication in deep brain stimulation. Zentralblatt Neurochirurgie 2002;63: 124-127.
94. Hariz MI, Johansson F. Hardware failure in parkinsonian patients with chronic subthalamic nucleus stimulation is a medical emergency. Mov Disord 2001;16:166-168.
95. Joint C, Nandi D, Parkin S, Gregory R, Aziz T. Hardware-related problems of deep brain stimulation. Mov Disord 2002;17:175-180.
96. Merello M, Cammarota A, Leiguarda R, Pikielny R. Delayed intracerebral electrode infection after bilateral STN implantation for Parkinson's disease: case report. Mov Disord 2001;16:168-170.
97. Raoul S, Faighel M, Rivier I, Verin M, Lajat Y, Damier P. Staged lesions through implanted deep brain stimulating electrodes: a new surgical procedure for treating tremor or dyskinesias. Mov Disord 2003;18:933-938.
98. Schwalb JM, Riina HA, Skolnick B, Jaggi JL, Simuni T, Baltuch GH. Revision of deep brain stimulator for tremor: technical note. J Neurosurg 2001;94:1010-1012.
99. Sharan A, Rezai AR. Comment on Oh et al., hardware-related complications of deep brain stimulation. Neurosurgery 2002;50: 1275.
100. Tronnier VM, Staubert A, Hahnel S, Sarem-Aslani A. Magnetic resonance imaging with implanted neurostimulators: an in vitro and in vivo study. Neurosurgery 1999;44:118-125.